Logo image of JUNE

JUNEE LTD (JUNE) Stock Fundamental Analysis

NASDAQ:JUNE - Nasdaq - VGG5294K1104 - Common Stock - Currency: USD

4.1299  +0.03 (+0.73%)

Fundamental Rating

2

Overall JUNE gets a fundamental rating of 2 out of 10. We evaluated JUNE against 71 industry peers in the Diversified Consumer Services industry. JUNE has a great financial health rating, but its profitability evaluates not so good. JUNE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year JUNE has reported negative net income.
JUNE had a negative operating cash flow in the past year.
JUNE Yearly Net Income VS EBIT VS OCF VS FCFJUNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K -1M

1.2 Ratios

JUNE has a Return On Assets of -13.56%. This is in the lower half of the industry: JUNE underperforms 67.19% of its industry peers.
JUNE has a Return On Equity (-15.58%) which is in line with its industry peers.
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JUNE Yearly ROA, ROE, ROICJUNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With a Gross Margin value of 26.83%, JUNE is not doing good in the industry: 73.44% of the companies in the same industry are doing better.
JUNE's Gross Margin has improved in the last couple of years.
JUNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
JUNE Yearly Profit, Operating, Gross MarginsJUNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

JUNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
JUNE has less shares outstanding than it did 1 year ago.
JUNE has a better debt/assets ratio than last year.
JUNE Yearly Shares OutstandingJUNE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
JUNE Yearly Total Debt VS Total AssetsJUNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

JUNE has an Altman-Z score of 31.59. This indicates that JUNE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of JUNE (31.59) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that JUNE is not too dependend on debt financing.
JUNE has a better Debt to Equity ratio (0.01) than 67.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 31.59
ROIC/WACCN/A
WACC10.53%
JUNE Yearly LT Debt VS Equity VS FCFJUNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

JUNE has a Current Ratio of 8.25. This indicates that JUNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.25, JUNE belongs to the top of the industry, outperforming 95.31% of the companies in the same industry.
A Quick Ratio of 8.25 indicates that JUNE has no problem at all paying its short term obligations.
The Quick ratio of JUNE (8.25) is better than 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 8.25
Quick Ratio 8.25
JUNE Yearly Current Assets VS Current LiabilitesJUNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for JUNE have decreased strongly by -7435.71% in the last year.
JUNE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.14%.
The Revenue for JUNE have been decreasing by -22.76% on average. This is quite bad
EPS 1Y (TTM)-7435.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2627.3%
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUNE Yearly Revenue VS EstimatesJUNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M
JUNE Yearly EPS VS EstimatesJUNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JUNE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUNE Price Earnings VS Forward Price EarningsJUNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUNE Per share dataJUNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JUNE!.
Industry RankSector Rank
Dividend Yield N/A

JUNEE LTD

NASDAQ:JUNE (2/21/2025, 8:00:02 PM)

4.1299

+0.03 (+0.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner Change-30.79%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.73M
AnalystsN/A
Price TargetN/A
Short Float %0.09%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.77
P/FCF N/A
P/OCF N/A
P/B 7.71
P/tB 7.71
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.35
BVpS0.54
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.83%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.87%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.25
Quick Ratio 8.25
Altman-Z 31.59
F-Score4
WACC10.53%
ROIC/WACCN/A
Cap/Depr(3y)87.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7435.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2627.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-466.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2590.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1767.85%
OCF growth 3YN/A
OCF growth 5YN/A